Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
The relationship between fear of falling to spatiotemporal gait parameters measured by an instrumented treadmill in people with multiple sclerosis.
Gender differences in multiple sclerosis: induction of estrogen signaling in male and progesterone signaling in female lesions.
Pain: Comorbidity of neuropathic pain and migraine in patients with multiple sclerosis.
Matrix metalloproteinases and their pathological upregulation in multiple sclerosis: an overview.
[Targeted Therapy and Progressive Multifocal Leukoencephalopathy (PML): PML in the Era of Monoclonal Antibody Therapies].
PERK Activation Preserves the Viability and Function of Remyelinating Oligodendrocytes in Immune-Mediated Demyelinating Diseases.
A Novel Multiparametric Approach to 3D Quantitative MRI of the Brain.
Antiretrovirals inhibit arginase in human microglia.
Genetic, Immune-Inflammatory, and Oxidative Stress Biomarkers as Predictors for Disability and Disease Progression in Multiple Sclerosis.
Role of Glia in Stress-Induced Enhancement and Impairment of Memory.
The Use of MiRNA Antagonists in the Alleviation of Inflammatory Disorders.
Sphingosine kinase 2 deficient mice exhibit reduced experimental autoimmune encephalomyelitis: Resistance to FTY720 but not ST-968 treatments.
A Novel CMKLR1 Small Molecule Antagonist Suppresses CNS Autoimmune Inflammatory Disease.
Why are prions and amyloid structures immune suppressive and other intriguing questions facing neuroimmunologists in the future.
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders.
Extracellular vesicles round off communication in the nervous system.
The melanocortin ACTH 1-39 promotes protection of oligodendrocytes by astroglia.
Correction: Immune Parameters That Distinguish Multiple Sclerosis Patients from Patients with Other Neurological Disorders at Presentation.
MHC-class-II are expressed in a subpopulation of human neural stem cells in vitro in an IFNγ-independent fashion and during development.
Cerebral infarction following subcutaneous immunoglobulin therapy for chronic inflammatory demyelinating polyradiculoneuropathy.
Altered tract-specific white matter microstructure is related to poorer cognitive performance: The Rotterdam Study.
Origins of oligodendrocytes in the cerebellum, whose development is controlled by the transcription factor, Sox9.
The Activators of Cyclin-Dependent Kinase 5 p35 and p39 Are Essential for Oligodendrocyte Maturation, Process Formation, and Myelination.
Advances in myelin imaging with potential clinical application to pediatric imaging.
Mesenchymal cells of umbilical cord and umbilical cord blood as a source of human oligodendrocyte progenitors.
Pages
« first
‹ previous
…
656
657
658
659
660
661
662
663
664
…
next ›
last »